Multiple Sclerosis Emerging Therapies Collaborative - UPDATE
November 14, 2011
The Multiple Sclerosis Emerging Therapies Collaborative – which includes the members of the MS Coalition, the American Academy of Neurology, and the VA Multiple Sclerosis Centers of Excellence East and West – has as its mission:
To develop and disseminate timely, evidence-based resources
to persons affected by multiple sclerosis and health care professionals,
in order to promote optimal, individualized treatment of the disease
by facilitating effective communication and medical decision-making
The emergence of new MS therapies is both exciting and challenging for people living with MS, the clinicians who treat them, and the organizations that serve them. The groups that form this Collaborative have united to speak with a single voice in an effort to promote understanding and reduce confusion within the MS community concerning newly emerging MS therapies.
The Collaborative has established a dedicated, rapid-response website that will present downloadable information sheets for professional and lay readers about each newly-approved treatment. The information sheets, which include the known benefits and risks of each treatment as well as answers to commonly-asked questions, are written to complement one another in order to promote clinician-patient communication. Users can direct questions to firstname.lastname@example.org.
New information about MS medications: The Collaborative has now posted information about the following medications and looks forward to adding additional resources in the near future:
Read more about the groups participating in this exciting new venture.